The U.S. Food and Drug Administration today announced the award of $2.9 million to support six research projects that will help with the diagnosis, treatment, and prevention of Pulmonary Tuberculosis TB. Pulmonary Tuberculosis TB remains a major public health challenge with an increasing prevalence worldwide. Two recent articles published by FDA’s Office of Critical Path Programs note that advances are urgently needed in TB drug development to shorten therapy and to treat drug-resistant disease. “FDA recognized an urgent need for the engagement and leadership of public health institutions to promote this critical, but neglected, area of medical therapeutics,” said FDA Commissioner Margaret A. Hamburg, M.D.


Miss, as is usually still have time playing with this distros. Since its first Backtrack release in the early 2007. Now Linux security distribution Backtrack has reach its fourth release
Re thinking about moving my blogger blog into this self-hosted wordpress Blog. Way?
